BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15918646)

  • 21. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
    Viale PH
    Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nausea and vomiting caused by anticancer drugs: state of the art.
    Pisters KM; Kris MG
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.
    Cefalo MG; Ruggiero A; Maurizi P; Attinà G; Arlotta A; Riccardi R
    J Chemother; 2009 Dec; 21(6):605-10. PubMed ID: 20071282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?
    Grunberg SM
    J Support Oncol; 2004; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy induced nausea and vomiting: a European perspective.
    Vidall C
    Br J Nurs; 2011 May 27-Jun 9; 20(10):S22, S25-8. PubMed ID: 21647008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical practice guidelines on antiemetics in oncology.
    Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
    Johnson MH; Moroney CE; Gay CF
    Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants.
    Gralla RJ; Roila F; Tonato M; ; ; ; ; ; ; ; ;
    Support Care Cancer; 2005 Feb; 13(2):77-9. PubMed ID: 15605253
    [No Abstract]   [Full Text] [Related]  

  • 31. Applying new data to manage CINV: achieving optimal outcomes through a comprehensive care model.
    Padezanin S
    ONS News; 2006; 21(8 Suppl):47-8. PubMed ID: 16925149
    [No Abstract]   [Full Text] [Related]  

  • 32. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
    National Comprehensive Cancer Network (NCCN)
    J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
    [No Abstract]   [Full Text] [Related]  

  • 33. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an anti-emetic protocol.
    Cook J; Gallagher A
    Paediatr Nurs; 1996 Sep; 8(7):21-3. PubMed ID: 9070770
    [No Abstract]   [Full Text] [Related]  

  • 35. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital.
    Caracuel F; Muñoz N; Baños U; Ramirez G
    J Oncol Pharm Pract; 2015 Jun; 21(3):163-9. PubMed ID: 24598374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of drug-induced nausea and vomiting].
    Herrstedt J; Dombernowsky P
    Ugeskr Laeger; 1994 Jan; 156(4):453-60. PubMed ID: 8140660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.